Matt Hobart is a Partner with TPG, a global private investment firm with $55.3 billion of assets under management. He leads the Healthcare and Financial Services investments for TPG Growth, the middle market and growth equity investment fund of TPG. Matt is currently a board member of Northstar Anesthesia, iMDsoft, Greencross Limited. Previous board service includes The Vincraft Group, Schiff Nutrition International, Wil Research and Agraquest. Prior to joining TPG Growth in 2004, Mr. Hobart was the Vice President of Corporate Development for Critical Path, where he was part of a turnaround team that led Critical Path through a major financial and operational restructuring. Previously, Matt co-founded and served as a Managing Director of Vectis Group, a venture corporation that capitalized and built companies globally, in partnership with leading U.S. technology businesses. Prior to Vectis Group, Mr. Hobart made private equity investments in the US and Europe for the $2.2 billion Morgan Stanley Capital Partners III L.P. and helped raise and invest the $350 million Morgan Stanley Global Emerging Markets Fund. Matt holds an MBA from Stanford University Graduate School of Business and a BA from Miami University.